Inventor · disambiguated record
Thomas G. Gant
Also filed as: GANT THOMAS · GANT THOMAS G · GANT THOMAS GEORGE
37 granted patents·164 pending applications·721 citations·filing 1999–2025
98Inventor score
Files withAUSPEX PHARMACEUTICALS INC174GANT THOMAS G8PFIZER7MILLENNIUM PHARM INC6AUSPEX PHARMACEUTICALS3
Top patents by PatentIndex Score
201 records- 0198US6235764B1Isothiazole derivatives useful as anticancer agentsPFIZER·Filed 1999·Granted May 22, 2001·261 cites·23 claims
- 0295US7638651B2Substituted cyclohexanonesAUSPEX PHARMACEUTICALS·Filed 2008·Granted Dec 29, 2009·38 cites·89 claims
- 0395US7456317B2Substituted phenethylamines with serotoninergic and/or norepinephrinergic activityAUSPEX PHARMACEUTICALS·Filed 2006·Granted Nov 25, 2008·23 cites·10 claims
- 0494US9296739B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Mar 29, 2016·21 cites·27 claims
- 0594US9233959B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Jan 12, 2016·22 cites·27 claims
- 0694US8524733B2Benzoquinoline inhibitors of vesicular monoamine transporter 2GANT THOMAS G·Filed 2009·Granted Sep 3, 2013·84 cites·3 claims
- 0794US7745665B2Substituted phenethylaminesAUSPEX PHARMACEUTICALS INC·Filed 2008·Granted Jun 29, 2010·24 cites·55 claims
- 0894US7598273B2Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic propertiesAUSPEX PHARMACEUTICALS INC·Filed 2006·Granted Oct 6, 2009·24 cites·12 claims
- 0993US8383823B2Substituted N-aryl pyridinonesAUSPEX PHARMACEUTICALS·Filed 2008·Granted Feb 26, 2013·15 cites·9 claims
- 1093US6380214B1Heterocyclic derivatives useful as anticancer agentsPFIZER·Filed 2000·Granted Apr 30, 2002·61 cites·2 claims
- 1192US7951810B2Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2006·Granted May 31, 2011·16 cites·19 claims
- 1292US7790902B2Isothiazole derivatives useful as anticancer agentsPFIZER·Filed 2008·Granted Sep 7, 2010·13 cites·2 claims
- 1392US7767860B2Substituted amino alcoholsAUSPEX PHARMACEUTICALS INC·Filed 2008·Granted Aug 3, 2010·6 cites·50 claims
- 1490US9814708B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·6 cites·39 claims
- 1590US9458082B2Substituted phenethylamines with serotoninergic and/or norepinephrinergic activityAUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·7 cites·20 claims
- 1690US9346800B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2013·Granted May 24, 2016·9 cites·20 claims
- 1790US8680123B1Substituted N-aryl pyridinonesAUSPEX PHARMACEUTICALS INC·Filed 2012·Granted Mar 25, 2014·9 cites·3 claims
- 1889US6548526B2Isothiazole derivatives useful as anticancer agentsPFIZER·Filed 2001·Granted Apr 15, 2003·25 cites·18 claims
- 1989US2024366591A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2087US8252933B22-oxo-1,2-dihydro-quinoline modulators of immune functionGANT THOMAS G·Filed 2009·Granted Aug 28, 2012·11 cites·28 claims
- 2186US7872013B2Preparation and utility of opioid analgesicsAUSPEX PHARMACEUTICALS INC·Filed 2007·Granted Jan 18, 2011·9 cites·20 claims
- 2285US7772248B2Preparation and utility of substituted imidazopyridine compounds with hypnotic effectsAUSPEX PHARMACEUTICALS INC·Filed 2007·Granted Aug 10, 2010·6 cites·17 claims
- 2384US2025326747A1Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2483US8227451B2Phenylacetic acid inhibitors of cyclooxygenaseGANT THOMAS G·Filed 2009·Granted Jul 24, 2012·2 cites·54 claims
- 2582US9550780B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Jan 24, 2017·4 cites·27 claims
- 2681US11033540B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Jun 15, 2021·0 cites·38 claims
- 2781US2022267317A1Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2879US8969575B2Substituted N-Aryl pyridinonesAUSPEX PHARMACEUTICALS INC·Filed 2013·Granted Mar 3, 2015·2 cites·22 claims
- 2978US7863308B2Substituted thiophenesAUSPEX PHARMACEUTICALS INC·Filed 2008·Granted Jan 4, 2011·2 cites·30 claims
- 3077US2021244723A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3176US9062001B2Substituted N-aryl pyridinonesAUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Jun 23, 2015·1 cites·17 claims
- 3276US6831091B2Salt forms of 3-(4-bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide and method of productionPFIZER·Filed 2001·Granted Dec 14, 2004·10 cites·37 claims
- 3376US2020172469A1Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic ActivityAUSPEX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3475US9504677B2Substituted N-aryl pyridinonesAUSPEX PHARMACEUTICALS INC·Filed 2015·Granted Nov 29, 2016·1 cites·19 claims
- 3574US10421710B2Substituted phenethylamines with serotoninergic and/or norepinephrinergic activityAUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Sep 24, 2019·1 cites·20 claims
- 3674US2020347048A1Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3773US11666566B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2020·Granted Jun 6, 2023·0 cites·18 claims
- 3873US8969576B2Substituted N-aryl pyridinonesAUSPEX PHARMACEUTICAL INC·Filed 2014·Granted Mar 3, 2015·1 cites·29 claims
- 3972US2019375746A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4070US2020060995A1Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic ActivityAUSPEX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4170US2021070798A1Inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
- 4269US9422225B2Substituted phenethylamines with serotoninergic and/or norepinephrinergic activityGANT THOMAS G·Filed 2008·Granted Aug 23, 2016·0 cites·17 claims
- 4369US8138226B2Substituted phenethylamines with serotoninergic and/or norepinephrinergic activityGANT THOMAS G·Filed 2008·Granted Mar 20, 2012·0 cites·28 claims
- 4469US2019083484A1Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4569US2015080427A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4669US2014350044A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4768US2014206712A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4868US2014206713A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4968US2018256517A1Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic ActivityAUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 5067US2017166562A1Benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 201 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas G. Gant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →